COPD - Nursing Case Study

Pathophysiology

• Primary mechanism: Chronic inflammation leads to structural changes in the airways and lung parenchyma, resulting in narrowed airways and destruction of alveolar walls, which reduces airflow and impairs gas exchange.

• Secondary mechanism: Excess mucus production and impaired ciliary function further obstruct airways, exacerbating airflow limitation and increasing the risk of infections.

• Key complication: Progressive airflow obstruction leads to hyperinflation and respiratory muscle dysfunction, causing increased work of breathing, decreased exercise tolerance, and eventual respiratory failure.

Patient Profile

Demographics:

68-year-old male, retired coal miner

History:

• Key past medical history: Chronic bronchitis, hypertension, type 2 diabetes

• Current medications: Albuterol inhaler, Lisinopril, Metformin, Tiotropium

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing shortness of breath

• Key symptoms: Persistent cough with sputum production, wheezing, fatigue, occasional chest tightness

• Vital signs: Blood pressure 148/92 mmHg, heart rate 96 bpm, respiratory rate 24 breaths per minute, oxygen saturation 88% on room air, temperature 98.6°F (37°C)

Section 1

Change in Patient Status:

During the patient's stay in the hospital, his respiratory status begins to deteriorate despite initial interventions. The nursing staff notices that his shortness of breath has worsened, and he is now using accessory muscles to breathe, indicated by intercostal retractions. His cough has become more persistent, and the sputum is now yellowish, suggesting a possible infection. His oxygen saturation has declined to 84% on room air, prompting the need for supplemental oxygen. The patient reports increasing fatigue and difficulty performing even simple tasks like speaking in full sentences.

In response to the change in status, the healthcare team conducts a more thorough assessment. Lung auscultation reveals diminished breath sounds with coarse crackles at the bases, and wheezing is more pronounced. A chest X-ray is ordered, revealing hyperinflation and patchy infiltrates, suggestive of an acute exacerbation of COPD possibly complicated by pneumonia. Blood tests show a leukocyte count of 13,000/mm³, indicating an inflammatory process, and arterial blood gas analysis reveals respiratory acidosis with a pH of 7.32, PaCO2 of 55 mmHg, and PaO2 of 58 mmHg.

These findings direct the clinical team to intensify management strategies. The patient is started on broad-spectrum antibiotics to address the suspected infection and systemic corticosteroids to reduce airway inflammation. Bronchodilator therapy is optimized, and he is placed on a high-flow nasal cannula to improve oxygenation. The nursing team closely monitors the patient's response to these interventions, assessing for signs of improvement or further deterioration, which will guide subsequent treatment decisions. This change in patient status underscores the importance of vigilant monitoring and timely intervention in managing COPD exacerbations to prevent progression to respiratory failure.

Section 2

Response to Interventions:

Following the initiation of intensified management strategies, the patient demonstrates a mixed response to the interventions. Within the first few hours, there is a slight improvement in his oxygen saturation, which rises to 88% on high-flow nasal cannula, indicating some benefit from increased oxygen delivery. The patient reports a modest reduction in dyspnea, although he still experiences significant fatigue and struggles with speaking. Despite these positive signs, the respiratory therapist notes that the patient's use of accessory muscles persists, and his breathing remains labored.

The nursing team continues to monitor the patient's vital signs and clinical status closely. His heart rate has increased to 110 bpm, and respiratory rate remains elevated at 28 breaths per minute. Blood pressure is slightly elevated at 145/88 mmHg. Repeat lung auscultation reveals that while the coarse crackles have lessened slightly, wheezing is still prominent, suggesting ongoing bronchial constriction. The nursing staff also observes that the patient is slightly more alert and able to engage in brief conversation, though his speech is punctuated by frequent pauses to catch his breath.

Despite initial improvements, the patient develops new complications. He starts to exhibit signs of anxiety and restlessness, possibly due to hypoxia or the systemic effects of corticosteroids. Additionally, there is concern about the potential for fluid overload, as the patient's legs appear more edematous, and his urine output has decreased slightly. These symptoms prompt the healthcare team to reassess the fluid management plan and consider diuretic therapy to prevent exacerbating respiratory distress. The unfolding situation requires ongoing clinical reasoning to balance the benefits of aggressive treatment with the risk of further complications. Continuous evaluation will be essential to optimize the patient's management and prevent further deterioration.

Section 3

Change in Patient Status:

As the healthcare team continues to monitor the patient, his condition begins to show signs of further deterioration, necessitating prompt clinical decision-making. Over the next few hours, the patient's respiratory rate increases to 32 breaths per minute, and his heart rate rises to 118 bpm, indicating increased respiratory distress and cardiac workload. The patient's oxygen saturation fluctuates between 85-87% despite continued high-flow oxygen support. His blood pressure remains elevated at 150/92 mmHg, and he becomes increasingly tachypneic and visibly anxious, suggesting that his respiratory effort is worsening.

In light of these changes, the nursing team performs a thorough reassessment. Lung auscultation reveals that wheezing has become more pronounced, and there are now diffuse crackles throughout both lung fields, suggesting fluid accumulation and potential worsening of heart failure. The patient also exhibits increased abdominal distention and mild jugular venous distension, raising concerns about right-sided heart strain or possible cor pulmonale. Furthermore, the patient's anxiety has intensified, and he becomes more irritable, struggling to maintain a coherent conversation due to breathlessness and fatigue.

These findings prompt an urgent multidisciplinary discussion to reassess the current treatment strategy. The team considers initiating diuretic therapy to address suspected fluid overload while carefully balancing the need for adequate oxygenation and maintaining stable hemodynamics. Consultation with the pulmonologist and cardiologist is sought to refine the management plan and explore the possibility of non-invasive ventilation or other advanced respiratory support options. This evolving clinical picture underscores the importance of continuous monitoring and dynamic adjustments to the treatment plan to prevent further complications and optimize patient outcomes.

Section 4

The healthcare team initiates diuretic therapy with intravenous furosemide, targeting the suspected fluid overload contributing to both pulmonary and systemic congestion. Within a few hours of administration, there is a modest improvement in the patient's respiratory effort, as evidenced by a slight decrease in respiratory rate to 28 breaths per minute. However, the patient's oxygen saturation remains concerning, fluctuating between 86-88% on high-flow oxygen support. Concurrently, his heart rate stabilizes slightly at 110 bpm, but he continues to exhibit signs of increased work of breathing and persistent anxiety.

New diagnostic results from a follow-up chest X-ray reveal bilateral pulmonary edema, consistent with the clinical suspicion of fluid overload and heart failure exacerbation. Additionally, an echocardiogram confirms the presence of right ventricular hypertrophy and mild to moderate tricuspid regurgitation, reinforcing the diagnosis of cor pulmonale secondary to chronic obstructive pulmonary disease (COPD). Laboratory tests reveal elevated brain natriuretic peptide (BNP) levels at 450 pg/mL, further supporting the diagnosis of heart failure.

These findings prompt a revision of the patient's management plan, with an emphasis on optimizing heart failure therapy and reconsidering the need for non-invasive ventilation to improve gas exchange and reduce respiratory distress. The team also decides to administer anxiolytic medication to alleviate the patient's anxiety, which is exacerbating his respiratory effort. This multidisciplinary approach aims to stabilize the patient's condition, prevent further deterioration, and enhance his overall comfort. As the team continues to monitor his response to these interventions, they remain vigilant for potential new complications that may arise in this complex clinical scenario.

Section 5

As the healthcare team implements the revised management plan, they closely monitor the patient's response to the interventions. Over the next 24 hours, the patient's respiratory status shows tentative signs of improvement. His respiratory rate decreases slightly to 24 breaths per minute, and his oxygen saturation begins to stabilize around 89-90% with the continued use of high-flow oxygen. The patient reports feeling marginally less anxious after receiving the anxiolytic medication, which appears to contribute to a modest reduction in his work of breathing. Heart rate remains stable at 100 bpm, indicating some relief in cardiac strain.

Despite these improvements, new complications arise as the patient develops signs of acute kidney injury (AKI), likely secondary to the aggressive diuretic therapy. Laboratory tests reveal an increase in serum creatinine from 1.1 mg/dL to 2.0 mg/dL, and blood urea nitrogen (BUN) rises from 18 mg/dL to 35 mg/dL. The patient also begins to exhibit mild hypokalemia, with serum potassium levels dropping to 3.2 mEq/L. These findings necessitate a careful re-evaluation of fluid management, with a potential need to adjust the dose of diuretics and initiate electrolyte replacement therapy.

In response to these developments, the healthcare team prioritizes renal protection strategies and adjusts the patient's medication regimen accordingly. They initiate a more conservative diuretic protocol to alleviate the strain on the kidneys while maintaining adequate pulmonary function. Potassium supplements are administered to correct the hypokalemia, and renal function is monitored closely with frequent laboratory assessments. This approach aims to balance the competing demands of managing heart failure symptoms while preventing further renal compromise. The team remains vigilant for additional complications and continues to assess the patient's overall response to the evolving treatment plan.